Pregled bibliografske jedinice broj: 1244127
The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg)
The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg) // Antibiotics, 10 (2021), 8; 965, 22 doi:10.3390/antibiotics10080965 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1244127 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Role of Statins on Helicobacter pylori
Eradication: Results from the European Registry on
the Management of H. pylori (Hp-EuReg)
Autori
Caldas, M ; Perez-Aisa, A ; Tepes, B ; Keco-Huerga, A ; Bujanda, L ; Lucendo, AJ ; Rodrigo, L ; Vaira, D ; Fernandez-Salazar, L ; Huguet, JM ; Perez-Lasala, J ; Jurecic, NB ; Fadeenko, G ; Barrio, J ; Areia, M ; Ortuno, J ; Pellicano, R ; Leja, M ; Molina-Infante, J ; Bogomolov, P ; Alekseenko, S ; Dominguez-Cajal, M ; Gomez-Camarero, J ; Ntouli, V ; Martinez- Dominguez, SJ ; Ruiz-Zorrilla, R ; Nunez, O ; Sarsenbaeva, AS ; Almela, P ; Phull, P ; Espada, M ; Puig, I ; Nyssen, OP ; Megraud, F ; O'Morain, C ; Gisbert, JP
Kolaboracija
Hp-EuReg Investigators
Izvornik
Antibiotics (2079-6382) 10
(2021), 8;
965, 22
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
statins ; Helicobacter pylori ; treatment
Sažetak
Statins could increase the effectiveness of Helicobacter pylori eradication therapies due to their anti-inflammatory effect. The aim of this study was to analyze the impact of this therapeutic association in real life. This is a multicenter, prospective, non-interventional study aimed at evaluating the management of H. pylori by European gastroenterologists. Patients were registered in an e-CRF by AEG-REDCap from 2013 to 2020. The association between statin use and H. pylori eradication effectiveness was evaluated through multivariate analysis. Overall, 9988 and 705 patients received empirical and culture-guided treatment, respectively. Overall, statin use was associated with higher effectiveness in the empirical group (OR = 1.3 ; 95%CI = 1.1-1.5), but no association was found with first-line treatment effectiveness (N = 7738) ; as an exception, statin use was specifically associated with lower effectiveness of standard triple therapy (OR = 0.76 ; 95%CI = 0.59-0.99). In the rescue therapy empirical group (N = 2228), statins were associated with higher overall effectiveness (OR = 1.9 ; 95%CI = 1.4-2.6). However, sub-analyses by treatment schemes only confirmed this association for the single-capsule bismuth quadruple therapy (OR = 2.8 ; 95%CI = 1.3-5.7). No consistent association was found between statin use and H. pylori therapy effectiveness. Therefore, the addition of statins to the usual H. pylori treatment cannot be currently recommended to improve cure rates.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus